Mohamad Mohty is full Professor of Hematology and head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France).
Professor Mohty obtained his medical degree from the University of Montpellier, France, and his PhD from the University of Marseille, France. He also undertook post-doctoral work at the Hematology Department, Imperial College, Hammersmith Hospital, London, UK.
Professor Mohty is also head of a translational research team (INSERM team N°7) at the Saint-Antoine Research centre in Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of novel immunomodulatory agents such as proteasome inhibitors, IMiDs and hypomethylating agents.
He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of acute leukemia and multiple myeloma.
Professor Mohty serves on the board of the European Society for Blood and Marrow Transplantation (EBMT), and the “Intergroupe Francophone du Myelome” (IFM). He is a member of the American Society of Hematology, American Society for Clinical Oncology, American Society for Blood and Marrow Transplantation, European Hematology Association, International Society for Experimental Hematology, and EBMT.
Professor Mohty has published more than 430 peer-reviewed articles in the field of stem cell transplantation, leukemia and myeloma, in different hematology and immunology journals.
He also serves as Editor-in-Chief of the journal Bone Marrow Transplantation, as Associate Editor for Leukemia, European Journal of Haematology and Blood Cancer Journal, as member of the editorial board of Haematologica, and as a regular reviewer in different immunology, hematology, and cancer journals such as Blood, The Lancet, and Nature Reviews.
He Huang, M.D., Ph.D., is the Dean of the First Affiliated Hospital, Zhejiang University School of Medicine; Director of Hematology Institution of Zhejiang University, Hangzhou, China. Prof. Huang specializes in clinical and basic research on hematopoietic stem cell transplantation, cellular immunotherapy and stem cell biology research. As corresponding author, he has published 206 original papers in SCI-cited journals including top journals in the field of hematology. For his outstanding achievement on hematopoietic stem cell transplantation, Pro. Huang was awarded the national prizes twice in 2003 and 2015, respectively.
Prof Didier Blaise, MD: Aix Marseille Univ (AMU), Management Sport Cancer Lab (MSC EA4670) Institut Paoli Calmettes (IPC) Marseille, France.
Didier Blaise, MD is professor of hematology at Aix Marseille University. He is director of the transplant and cellular immunotherapy program at Institut Paoli Calmettes, Marseille. He has contributed to more than 600 peer reviewed publications. His major focuses are optimization, social and economic evaluation of innovation in allogeneic transplantation.
Professor Arnon Nagler, MD, MSc Chaim Sheba Medical Center, Israel
Director of the Division of Hematology, Chaim Sheba Medical Center, Israel
Director of Bone Marrow transplantation and Cord Blood Bank, Chaim Sheba Medical Center, Israel
Professor of Medicine at the Tel Aviv University, Tel Aviv, Israel
One of the pioneers of the non-myeloablative and reduced intensity/toxicity allogeneic transplantations for both malignant and non-malignant disorders (Blood 1998)
Established the first public cord blood bank and performed the first cord blood transplanataion in Israel
Leader of the Alternative donor subcommittee of the ALWP of the EBMT from 2008-2010
Leader of the RIC subcommittee of the ALWP of the EBMT – since 2010
Serves on the Editorial Board of several BMT and Hematology Journals and is a Section Editor for Leukemia
Chair of the Acute Leukemia Working Party (ALWP) of the EBMT
Dr Nagler received his medical training at the Hebrew University-Hadassah Medical School, Jerusalem, Israel; he then carried out a Postdoctoral research fellowship in hematology and bone marrow transplantation at “Stanford University Hospital” Palo Alto, CA, in the USA, from 1986 to 1990.
Dr Nagler serves on the Board of Directors of Netcord organization of cord blood banks and was the Netcord Threasurer from 2010-2013.
Dr Nagler has received several awards including the best scientific abstract award of the ASBMT/CIBMR Tandem meeting (2004) and the best clinical abstract award of the NMDP Council Meeting (2004). In addition, Dr Nagler is a popular speaker and has made numerous, invited, international presentations and many Oral presentations on almost annual basis in all international transplantation and hematology meetings – ASH,ASBMT/CIBMTR, EBMT, EHA, Exp Hematology (including a presentation at the presidential symposium) and invited presentation at the Gordon conference (Boston USA).
This site place cookies on your machine for reasons including keeping track of your preferences, collecting aggregated statistics to analyze how our site is used, and to show you ads tailored to your interests. ACCEPT
Privacy, Cookies Policy, General Terms and Conditions of Use
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.